Table 6.
Demographics, clinical data and laboratory perameter at admission in survivors and non-survivors of patients with HFRS.
| Variables | Survivors (n = 133) | Non-survivors (n = 13) | P-value |
|---|---|---|---|
| Male, n (%) | 100 (75.2) | 9 (69.2) | 0.891 |
| Age, years | 43.92 ± 16.18 | 55.76 ± 10.28 | 0.010 |
| Max temperature, °C | 38.99 ± 0.75 | 38.91 ± 0.77 | 0.723 |
| Admitted days after fever | 5.99 ± 3.59 | 6.46 ± 3.07 | 0.645 |
| SBP, mmHg | 121.17 ± 17.94 | 114.69 ± 22.50 | 0.226 |
| DBP, mmHg | 78.81 ± 13.09 | 69.85 ± 22.36 | 0.030 |
| Smoking, n (%) | 63 (47.4) | 8 (61.5) | 0.329 |
| Alcohol consumption, n (%) | 59 (44.4) | 7 (53.8) | 0.512 |
| COMORBIDITY | |||
| Hypertension, n (%) | 20 (15) | 3 (23.1) | 0.718 |
| Diabetes mellitusm, n (%) | 5 (3.8) | 2 (15.4) | 0.119 |
| Coronary heart disease, n (%) | 4 (3) | 1 (7.7) | 0.377 |
| HFRS-RELATED COMPLICATION | |||
| Hemorrhage, n (%) | 71 (53.4) | 12 (92.3) | 0.007 |
| Bacterial infection, n (%) | 76 (57.1) | 11 (84.6) | 0.054 |
| Hepatic injury, n (%) | 68 (51.1) | 10 (76.9) | 0.075 |
| Sepsis, n (%) | 2 (1.5) | 4 (30.8) | 0.001 |
| MODS, n (%) | 2 (1.5) | 6 (46.2) | <0.001 |
| Arrhythmia, n (%) | 9 (6.8) | 0 | 1.000 |
| Blood transfusion, n (%) | 44 (33.1) | 11 (84.6) | 0.001 |
| CRRT, n (%) | 28 (21.1) | 11 (84.6) | <0.001 |
| Hospital stay, days | 13.28 ± 7.11 | 9.08 ± 6.47 | 0.042 |
| LABORATORYPARAMETERS | |||
| WBC, × 109 cells/L | 11.78 ± 7.66 | 13.66 ± 6.79 | 0.395 |
| PLT, × 109 cells/L | 86.23 ± 79.07 | 54.92 ± 44.68 | 0.163 |
| Neutrophils percentage, (%) | 66.38 ± 15.20 | 77.34 ± 10.16 | 0.012 |
| Lymphocytes percentage, (%) | 1.72 (2.86) | 1.69 (1.34) | 0.031 |
| PCT, (ng/ml) | 1.22 (0.03-62.91) | 7.65 (1.06–58.53) | <0.001 |
| Lg PCT | 0.10 ± 0.68 | 0.87 ± 0.48 | <0.001 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; MODS, multiple organ dysfunction syndrome; CRRT, continuous renal replacement therapy; WBC, white blood cell count; PLT, platelet; Lg PCT, procalcitonin after log10 transformation.